Compound dossier · evidence, sources, and tracked market
Oral GLP-1 agonist Strong evidence 0 cited studies 1 tracked vendor
The one vendor carrying Orforglipron with a Vendor Score of 80+
Lab-verifiable COAs
24 of 26 COAs open at Freedom DiagnosticsRing: share of COAs openable at the lab · numeral: Vendor Score
Tiers name what a vendor publishes, not a verdict on any product's purity or quality. Lab-verifiable COAs: certificates that open on the testing lab's own site (the seal's ring shows what share of them do). Third-party COAs: certificates attributed to a third-party lab, which may be hosted only on the vendor's site. Tiers follow the Vendor Score (90+ and 80–89), which is 87% COA evidence; the numeral in each seal is that score. Affiliate relationships never affect tiers, selection or order. How the Vendor Score works
An oral small-molecule GLP-1 receptor agonist candidate studied in metabolic research.
Evidence brief
Orforglipron is an oral, small-molecule (nonpeptide) GLP-1 receptor agonist in late-stage clinical development for type 2 diabetes and obesity; unlike injectable GLP-1 drugs it is a synthetic non-peptide taken by mouth, and most of the evidence comes from manufacturer-sponsored randomized trials.
Published dosing & study context → Reconstitution calculator →
first-party prices captured
Newly FDA-approved: Foundayo (NDA 220934), an oral GLP-1 receptor agonist for chronic weight management in adults with obesity, or overweight with at least one weight-related condition. It has no EMA authorisation; trials continue in the EU and UK, where it remains investigational. Research use only — not medical advice.
Source: Foundayo (orforglipron) prescribing information · DailyMed checked 2026-08-15
Price includes the displayed code where available. Shipping and tax are extra. Unknown sizes or prices are excluded when those filters are set.
Selections stay on this browser. Prices and stock come from the current page; review freshness and COA notes for each offer. Scroll sideways to see every offer.
Select up to four offers to compare side by side. Click a column heading to sort. Click again to reverse. Scroll sideways for more columns.
Tick up to four offers to compare side by side. Use Sort by to reorder. COA counts are each vendor's own library; batch match is not assumed.
| Select | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Happy Peptides | OrforglipronOrforglipron · Not in price comparison | Vial / standard | 90 | $95.00 | — | in stock | 80/100 | 3 indexedVendor library; batch match not assumed | Checked within 24 hoursPrice and stock were collected in the latest refresh.just now | View product ↗ | |
| Happy Peptides | OrforglipronOrforglipron · Bulk | Vial / standard | 270 | $165.00 | $0.61 | in stock | 80/100 | 3 indexedVendor library; batch match not assumed | Checked within 24 hoursPrice and stock were collected in the latest refresh.just now | View product ↗ | |
| Regentide | Orforglipron 6mg GLP1-O (90 Capsules)Orforglipron · Not in price comparison | oral | 6 | $279.99 | — | in stock | 5/100 | COA detailsVendor library; batch match not assumed | Checked within 24 hoursPrice and stock were collected in the latest refresh.just now | View product ↗ | |
| Swiss Chems | Orforglipron 6mg / 90capsOrforglipron | Vial / standard | 6 | $198.95 | $33.16 | in stock | 98/100 | 26 indexedVendor library; batch match not assumed | Checked within 24 hoursPrice and stock were collected in the latest refresh. | View product ↗ | |
| Atomik Labz | Orforglipron CapsulesOrforglipron · Not in price comparison | oral | 6 | $99.00 | — | in stock | 35/100 | 99 indexedVendor library; batch match not assumed | Checked within 24 hoursPrice and stock were collected in the latest refresh. | View product ↗ | |
| Bulk Peptides | Orforglipron 6mg – 4 bottles x 60 capsules (240 capsules) –Orforglipron · Not in price comparison | oral | 6 | $240.00 | — | in stock | 87/100 | 9 indexedVendor library; batch match not assumed | Checked within 24 hoursPrice and stock were collected in the latest refresh. | View product ↗ | |
| My Oasis Labs | Orforglipron 6mg Capsules (60ct)Orforglipron · Not in price comparison | oral | 6 | $179.00 | — | in stock | 92/100 | 117 indexedVendor library; batch match not assumed | Checked within 24 hoursPrice and stock were collected in the latest refresh. | View product ↗Affiliate link: pepmg may earn a commission. Affiliate status never affects ranking, price order or Vendor Scores. | |
| Southern Aminos | ORFORGLIPRON TABLETSOrforglipron · Not in price comparison | oral | 6 | $250.00 | — | out of stock | 74/100 | 10 indexedVendor library; batch match not assumed | Checked within 24 hoursPrice and stock were collected in the latest refresh. | View product ↗ | |
| Solution Peptides | Orforglipron Capsules 6mgOrforglipron · Not in price comparison | oral | 6 | $99.00 | — | in stock | 35/100 | 164 indexedVendor library; batch match not assumed | Checked within 24 hoursPrice and stock were collected in the latest refresh. | View product ↗ | |
| LiveWell Peptides | Orforglipron — 6mg Tablets (90ct)Orforglipron · Not in price comparison | oral | 6 | $175.00 | — | Last known: in stock | 80/100 | 29 indexedVendor library; batch match not assumed | Last known priceNot reconfirmed in the latest refresh. Stock is also last known.38h ago | View product ↗ | |
| PureRawz | Orforglipron 12mg per tab 90ct 1080mg Sublingual TabletsOrforglipron · Not in price comparison | oral | 12 | $380.48 | — | Last known: in stock | 72/100 | 100 indexedVendor library; batch match not assumed | Last known priceNot reconfirmed in the latest refresh. Stock is also last known.2d ago | View product ↗ |
No matches. Try another search or reset the filters.
Orforglipron is an oral, small-molecule (nonpeptide) GLP-1 receptor agonist in late-stage clinical development for type 2 diabetes and obesity; unlike injectable GLP-1 drugs it is a synthetic non-peptide taken by mouth, and most of the evidence comes from manufacturer-sponsored randomized trials.
Read the full review →Source-linked reference figures with the population and study context alongside each amount. Study arms are not a starting dose, titration schedule, or personal treatment plan. Label records refer to the named approved medicine, not vendor products.
0.8 mg once daily, 2.5 mg once daily, 5.5 mg once daily, 9 mg once daily, 14.5 mg once daily, or 17.2 mg once daily
human · chronic weight management in adults with obesity, or overweight with at least one weight-related condition, alongside a reduced-calorie diet and increased physical activity · FDA label (Foundayo) · Route reported: oral
Read original source: Foundayo (orforglipron) FDA prescribing information, DailyMed ↗6 mg once daily, 12 mg once daily, or 36 mg once daily
human · adults with obesity without diabetes mellitus · phase 3 randomised double-blind trial (ATTAIN-1) · Route reported: oral
Read original source: PMID 40960239 ↗3 mg once daily, 12 mg once daily, or 36 mg once daily
human · adults with early type 2 diabetes treated with diet and exercise only · phase 3 randomised double-blind trial (ACHIEVE-1) · Route reported: oral
Read original source: PMID 40544435 ↗Research use only — this reports what an FDA label or a peer-reviewed study published, tied to its species and study context. It is not medical advice, not a recommendation to use, and no dose here is generated by pepmg. Any dosing decision is for a qualified professional. Animal-study amounts do not establish a human dose.
Reconstitution calculator → · Converts your entered quantities; it does not select a dose or establish suitability for use.
Prices for this compound vary widely between vendors; comparing $/mg avoids overpaying.
Always check each vendor's third-party Certificate of Analysis (COA) for identity and purity.
| GLP3 RT | $1.83/mg | |
| GLP2 TZ | $1.22/mg | |
| GLP1 S | $1.22/mg | |
| Cagrilintide | $4.60/mg | |
| AOD-9604 | $3.50/mg | |
| HGH Frag 176-191 | $5.73/mg | |
| 5-Amino-1MQ | $0.80/mg | |
| Survodutide | $4.87/mg | |
| Mazdutide | $5.25/mg | |
| Teduglutide | $2.12/mg | |
| Tesofensine | $196.00/mg | |
| SLU-PP-332 | $2.50/mg | |
| BAM15 | $1.96/mg | |
| AICAR | $0.63/mg | |
| Adipotide | $7.70/mg | |
| L-Carnitine | —/mg |
Ask how pepmg works: reading a price row, the Vendor Score, COA tiers, where prices and doses come from. Every answer links the section it comes from.
All help topics